Brovana Related Published Studies
Well-designed clinical trials related to Brovana (Arformoterol Inhalation)
The safety and efficacy of arformoterol and formoterol in COPD. [2010.02]
Comparison of the efficacy and safety of arformoterol 15 microg twice daily and arformoterol 30 microg once daily in COPD: a single-dose, multicenter, randomized, modified-blind, two-way crossover study. [2009.08]
Effects of arformoterol twice daily, tiotropium once daily, and their combination in patients with COPD. [2009.04]
Arrhythmias in patients with chronic obstructive pulmonary disease (COPD): occurrence frequency and the effect of treatment with the inhaled long-acting beta2-agonists arformoterol and salmeterol. [2008.11]
Nebulized arformoterol in patients with COPD: A 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial. [2007.02]
Well-designed clinical trials possibly related to Brovana (Arformoterol Inhalation)
Safety and Tolerability of High-Dose Budesonide/Formoterol via Turbuhaler(R) in Japanese Patients with Asthma: A Randomized, Double-Blind, Crossover, Active Comparator-Controlled, Phase III Study. [2012.01.01]
Management of asthma in pregnancy guided by measurement of fraction of exhaled nitric oxide: a double-blind, randomised controlled trial. [2011.09.10]
Efficacy of budesonide/formoterol pressurized metered-dose inhaler versus budesonide pressurized metered-dose inhaler alone in Hispanic adults and adolescents with asthma: a randomized, controlled trial. [2011.09]
Bronchodilator responsiveness and onset of effect with budesonide/formoterol pMDI in COPD. [2011.08]
Budesonide/formoterol maintenance and reliever therapy versus conventional best standard treatment in asthma in an attempted 'real life' setting. [2011.07]
Comparing asthma treatment in elderly versus younger patients. [2011.06]
Effects of formoterol and tiotropium bromide on mucus clearance in patients with COPD. [2011.06]
Efficacy and safety of fluticasone and formoterol in a single pressurized metered dose inhaler. [2011.05]
Rapid onset of bronchodilation with formoterol/beclomethasone Modulite and formoterol/budesonide Turbuhaler as compared to formoterol alone in patients with COPD. [2011.02]
Combined treatment with formoterol and tiotropium is more efficacious than treatment with tiotropium alone in patients with chronic obstructive pulmonary disease, regardless of smoking status, inhaled corticosteroid use, baseline severity, or gender. [2011.02]
Sodium cromoglycate and eformoterol attenuate sensitivity and reactivity to inhaled mannitol in subjects with bronchiectasis. [2011.01]
Application of latent growth and growth mixture modeling to identify and
characterize differential responders to treatment for COPD. [2011]
Long-term safety of mometasone furoate/formoterol combination for treatment of patients with persistent asthma. [2010.12]
A randomized, open labeled, comparative study to assess the efficacy and safety of controller medications as add on to inhaled corticosteroid and long-acting beta2 agonist in the treatment of moderate-to-severe persistent asthma. [2010.10]
Budesonide added to formoterol contributes to improved exercise tolerance in patients with COPD. [2010.10]
Effectiveness and safety of adjustable maintenance dosing with budesonide/formoterol turbuhaler compared with traditional fixed doses in bronchial asthma: a multi-centre Nigerian study. [2010.09]
Comparison of two twice-daily doses of budesonide/formoterol maintenance and reliever therapy. [2010.09]
Economic evaluation of BDP/formoterol fixed vs two single inhalers in asthma treatment. [2010.09]
Effects of extra-fine inhaled beclomethasone/formoterol on both large and small airways in asthma. [2010.07]
Protective effect of budesonide/formoterol compared with formoterol, salbutamol and placebo on repeated provocations with inhaled AMP in patients with asthma: a randomised, double-blind, cross-over study. [2010.05.28]
Long-acting beta-agonists with and without inhaled corticosteroids and catastrophic asthma events. [2010.04]
Formoterol for acute asthma in the emergency department: a systematic review with meta-analysis. [2010.03]
Effects of budesonide and formoterol on allergen-induced airway responses, inflammation, and airway remodeling in asthma. [2010.02]
Efficacy and safety of budesonide/formoterol pressurized metered-dose inhaler: randomized controlled trial comparing once- and twice-daily dosing in patients with asthma. [2010.01]
The functionality of a budesonide/formoterol pressurized metered-dose inhaler with an integrated actuation counter. [2010.01]
Comparative bioavailability of two hydrofluoroalkane formulations of formoterol fumarate both delivered by pressurised metered dose inhaler. [2010]
Treatment comparison of budesonide/formoterol with salmeterol/fluticasone propionate in adults aged > or =16 years with asthma: post hoc analysis of a randomized, double-blind study. [2010]
Impact of tiotropium on the course of moderate-to-very severe chronic obstructive
pulmonary disease: the UPLIFT trial. [2010]
Single maintenance and reliever therapy (SMART) of asthma: a critical appraisal. [2010]
Can patients with asthma feel inhaler therapy working right away? Two clinical trials testing the effect of timing of assessment on patient perception. [2009.12]
The bioavailability and airway clearance of the steroid component of budesonide/formoterol and salmeterol/fluticasone after inhaled administration in patients with COPD and healthy subjects: a randomized controlled trial. [2009.10.31]
Efficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary disease. [2009.10.15]
A comparison of budesonide/formoterol maintenance and reliever therapy vs. conventional best practice in asthma management. [2009.10]
[Prospective evaluation of the efficacy of the combination of budesonide/formoterol in obstructive airway disease after allogeneic hematopoietic stem cell transplantation] [2009.09]
A randomized, comparative study of formoterol and terbutaline dry powder inhalers in the treatment of mild to moderate asthma exacerbations in the pediatric acute care setting. [2009.09]
Efficacy and safety of nebulized formoterol as add-on therapy in COPD patients receiving maintenance tiotropium bromide: Results from a 6-week, randomized, placebo-controlled, clinical trial. [2009.06.18]
[Effect of transfer factor on treatment with glucocorticoids in a group of pediatric patients with persistent moderate allergic asthma] [2009.05]
Airway inflammation in patients with asthma with high-fixed or low-fixed plus as-needed budesonide/formoterol. [2009.05]
Effect of formoterol with or without budesonide in repeated low-dose allergen challenge. [2009.04]
Budesonide/formoterol as effective as prednisolone plus formoterol in acute exacerbations of COPD. A double-blind, randomised, non-inferiority, parallel-group, multicentre study. [2009.02.19]
Lung function and asthma control with beclomethasone and formoterol in a single inhaler. [2009.01]
Efficacy and safety of nebulized formoterol as add-on therapy in COPD patients receiving maintenance tiotropium bromide: Results from a 6-week, randomized, placebo-controlled, clinical trial. [2009]
Systemic exposure and implications for lung deposition with an extra-fine hydrofluoroalkane beclometasone dipropionate/formoterol fixed combination. [2009]
Patient-reported outcomes in adults with moderate to severe asthma after use of budesonide and formoterol administered via 1 pressurized metered-dose inhaler. [2008.11]
Formoterol mono- and combination therapy with tiotropium in patients with COPD: a 6-month study. [2008.11]
Anti-inflammatory effects of combined budesonide/formoterol in COPD exacerbations. [2008.10]
Inflammatory and functional effects of increasing asthma treatment with formoterol or double dose budesonide. [2008.10]
Onset of effect of budesonide and formoterol administered via one pressurized metered-dose inhaler in patients with asthma previously treated with inhaled corticosteroids. [2008.09]
Long-term safety and asthma control with budesonide/formoterol versus budesonide pressurized metered-dose inhaler in asthma patients. [2008.09]
Equivalence of a single saline nebulised dose of formoterol powder vs three doses of nebulised Albuterol every twenty minutes in acute asthma in children: a suitable cost effective approach for developing nations. [2008.07]
[Immediate bronchodilator response to formoterol in poorly reversible chronic obstructive pulmonary disease] [2008.06]
Early bronchodilatory effects of budesonide/formoterol pMDI compared with fluticasone/salmeterol DPI and albuterol pMDI: 2 randomized controlled trials in adults with persistent asthma previously treated with inhaled corticosteroids. [2008.05]
Concomitant treatment with nebulized formoterol and tiotropium in subjects with COPD: A placebo-controlled trial. [2008.04]
Efficacy of formoterol Turbuhaler in the emergency treatment of patients with obstructive airway diseases. [2008.04]
Long duration of airway but not systemic effects of inhaled formoterol in asthmatic patients. [2008.03]
Poor adherence with inhaled corticosteroids for asthma: can using a single inhaler containing budesonide and formoterol help? [2008.01]
Tolerability of high cumulative doses of the HFA modulite beclomethasone dipropionate/formoterol combination inhaler in asthmatic patients. [2008]
Efficacy and safety of once or twice daily inhalation of extrafine HFA beclomethasone dipropionate in patients with mild to moderate asthma. [2007.11]
Therapeutic comparison of a new budesonide/formoterol pMDI with budesonide pMDI and budesonide/formoterol DPI in asthma. [2007.11]
Cardiac safety profile of nebulized formoterol in adults with COPD: a 12-week, multicenter, randomized, double- blind, double-dummy, placebo- and active-controlled trial. [2007.10]
Effects of formoterol on exercise tolerance in severely disabled patients with COPD. [2007.10]
Tiotropium is less likely to induce oxygen desaturation in stable COPD patients compared to long-acting beta2-agonists. [2007.08]
Acute asthma intervention: insights from the STAY study. [2007.06]
A randomised, double-blind, placebo-controlled study to evaluate the role of formoterol in the management of acute asthma. [2007.05]
Overcoming beta-agonist tolerance: high dose salbutamol and ipratropium bromide. Two randomised controlled trials. [2007.03.06]
Randomised trial comparing as-needed versus regular treatment with formoterol in patients with persistent asthma. [2007.03]
The effects of inhaled budesonide and formoterol in combination and alone when given directly after allergen challenge. [2007.02]
Onset of relief of dyspnoea with budesonide/formoterol or salbutamol following methacholine-induced severe bronchoconstriction in adults with asthma: a double-blind, placebo-controlled study. [2006.12.04]
The effect of formoterol inhalation on endurance performance in hypobaric conditions. [2006.12]
Effect of formoterol fumarate treatment on exercise-induced bronchoconstriction in children. [2006.09]
Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study. [2006.08.26]
Comparison of the acute effect of tiotropium versus a combination therapy with single inhaler budesonide/formoterol on the degree of resting pulmonary hyperinflation. [2006.07]
Comparison of asthma treatment given in addition to inhaled corticosteroids on airway inflammation and responsiveness. [2006.06]
Maintenance plus reliever budesonide/formoterol compared with a higher maintenance dose of budesonide/formoterol plus formoterol as reliever in asthma: an efficacy and cost-effectiveness study. [2006.05]
Acute relief of exercise-induced bronchoconstriction by inhaled formoterol in children with persistent asthma. [2006.05]
Efficacy and safety of high-dose budesonide/formoterol (Symbicort) compared with budesonide administered either concomitantly with formoterol or alone in patients with persistent symptomatic asthma. [2006.05]
Inhaled formoterol versus ipratropium bromide in chronic obstructive pulmonary disease. [2006.04]
Safety and tolerability of high-dose formoterol (via Aerolizer) and salbutamol in patients with chronic obstructive pulmonary disease. [2006.04]
Adjustable maintenance dosing with budesonide/formoterol or budesonide: double-blind study. [2006.03]
Budesonide/formoterol in a single inhaler for maintenance and relief in mild-to-moderate asthma: a randomized, double-blind trial. [2006.02]
Effect of formoterol/budesonide combination on arterial blood gases in patients with acute exacerbation of COPD. [2006.02]
Budesonide/formoterol and formoterol provide similar rapid relief in patients with acute asthma showing refractoriness to salbutamol. [2006.01.24]
The 24 h duration of bronchodilator action of the budesonide/formoterol combination inhaler. [2006.01]
Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial. [2006]
Is there any difference between effects of ipratropium bromide and formoterol on exercise capacity in moderate COPD patients? [2006]
Onset and duration of action of formoterol and tiotropium in patients with moderate to severe COPD. [2006]
Clinically equivalent bronchodilatation achieved with formoterol delivered via Easyhaler and Aerolizer. [2006]
Formoterol induces tolerance to the bronchodilating effect of Salbutamol following methacholine-provocation test in asthmatic children. [2006]
Efficacy and safety of budesonide/formoterol compared with salbutamol in the treatment of acute asthma. [2006]
Tolerance to bronchodilation during treatment with long-acting beta-agonists, a randomised controlled trial. [2005.09.16]
Bronchoprotection with formoterol via dry powder and metered-dose inhalers in patients with asthma. [2005.09]
Comparison of the short-term effects of salmeterol and formoterol on heart rate variability in adult asthmatic patients. [2005.09]
Formoterol added to low-dose budesonide has no additional antiinflammatory effect in asthmatic patients. [2005.09]
Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD. [2005.08]
Improvement of asthma control with beclomethasone extrafine aerosol compared to fluticasone and budesonide. [2005.06]
Bronchodilator response to formoterol after regular tiotropium or to tiotropium after regular formoterol in COPD patients. [2005.05]
|
